$PROV

Net loan losses of Provident Financial Holdings, Inc. – NASDAQ:PROV

This article provides financial data specifically on the net loan losses of Provident Financial Holdings, Inc. (NASDAQ: PROV). The content includes a brief overview of the company's stock information, focusing on its financial performance under the "Net loan losses" section. It primarily serves as a data point for investors and analysts interested in the company's loan loss metrics.

Original reporting
Published May 9, 2026, 6:09 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 9, 2026, 6:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Net loan losses of Provident Financial Holdings, Inc. – NASDAQ:PROV — source image
Decision brief

The 30-second read

$PROVBearishMed
01

Why it matters

The data suggests heightened credit risk, which could pressure the stock price in the near term.

02

Market read

While relevant to regional banking investors, the impact on broader markets is limited.

03

What to watch

Potential for upcoming earnings reports or macroeconomic data to offset current concerns.

Relevance 6/10Timing: Immediate, as financial data impacts trading decisions today.

Background

Provident Financial Holdings, Inc. has reported increased net loan losses, signaling potential asset quality issues.

Company-level read

Ticker impact

$PROVBearishMedium confidence
Context

Financial performance indicator focusing on net loan losses.

Expected impact

Potential short-term decline of 3-5% based on current loan loss figures.

Evidence & confidence

Loan loss data is a key indicator of financial health; however, without broader context such as overall earnings or macroeconomic factors, the prediction remains moderate.

Market effects

Potential negative impact on regional banking sector sentiment.

Limited, as Provident Financial Holdings is a regional player.

Negligible, given the company's regional focus and the specific nature of loan losses.

Counterpoint

The loan loss figures may be a temporary provisioning, and the company could recover if macroeconomic conditions improve.

Key entities

  • Provident Financial Holdings, Inc.

    A regional financial services company focusing on banking and lending.

Related articles

$PROVMed

PROVIDENT FINANCIAL HOLDINGS REPORTS FOURTH QUARTER AND FISCAL 2026 RESULTS

PROVIDENT FINANCIAL HOLDINGS INC (PROV) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 prov8k72826exh991.htm Exhibit 99.1 3756 Central Avenue NEWS RELEASE Riverside, CA 92506 (951) 686-6060 PROVIDENT FINANCIAL HOLDINGS REPORTS FOURTH QUARTER AND FISCAL 2026 RESULTS Net Income of $2.18 million in the June 2026 Quarter, Up 61% from the Sequential Quarter an

$RCLHigh

Jefferies upgrades Royal Caribbean stock rating on improved revenue outlook

Jefferies upgraded Royal Caribbean (RCL) to Buy with a $330 price target, citing improved occupancy and revenue per passenger. RCL trades at $282.32, with a P/E ratio of 17.66. Jefferies raised revenue estimates for Q3 2026 and FY 2027, projecting net yield growth and higher EBITDA. Despite lower EPS estimates, the firm increased valuation multiples. Other analysts also upgraded RCL, citing strategic developments and positive yield outlooks.

$NGNEHigh

JPMorgan initiates Neurogene stock rating at Overweight on gene therapy potential

JPMorgan initiated coverage on Neurogene Inc. (NASDAQ: NGNE) with an Overweight rating and a $60.00 price target, citing potential in its gene therapy NGN-401 for Rett syndrome. The stock trades at $25.87, with analysts maintaining a Strong Buy consensus. Neurogene expects key data readouts in 2H27, with a market cap of $518 million and high volatility. Recent analyst adjustments include lowered price targets from H.C. Wainwright and Canaccord, both maintaining Buy ratings.